This table presents recent patent oppositions filed by Boehringer Ingelheim International Gmbh against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3165600Cell Culture Medium Comprising Small PeptidesLIFE TECHNOLOGIES CORPORATIONAug 1, 2023
EP3874047Carbon-Source Regulated Protein Production In A Recombinant Host CellLONZA LTD.Jan 9, 2023
EP3342786Anti-Dll3 AntibodyCHUGAI SEIYAKU KABUSHIKI KAISHAMar 22, 2022
EP3541387Dose And Regimen For Hdm2-P53 Interaction InhibitorsNOVARTIS AGJan 20, 2022
EP3177645Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLINDHOFER, HORST, DR.Nov 16, 2021
EP3160463Intermittent Dosing Of Mdm2 InhibitorNOVARTIS AGJul 16, 2021
EP2820151Cancer Patient Selection For Administration Of Wnt Signaling Inhibitors Using Rnf43 Mutation StatusIRM LLCDec 15, 2020
EP2847223Anti-B7-H6 Antibody, Fusion Proteins, And Methods Of Using The SameTRUSTEES OF DARTMOUTH COLLEGEDec 20, 2019
EP2647707Cytotoxicity-Inducing Therapeutic AgentCHUGAI SEIYAKU KABUSHIKI KAISHAJun 12, 2019
EP2530091Anti-Dll3 AntibodyCHUGAI SEIYAKU KABUSHIKI KAISHAJan 2, 2019

The following table provides an overview of the latest patents of Boehringer Ingelheim International Gmbh that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP2395968Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A Patient18
EP2313087Nov 22, 2023Pharmaceutical Dosage Form For Immediate Release Of An Indolinone Derivative3
EP3110449Jun 28, 2023Medical Use Of A Dpp-4 Inhibitor5
EP3802922Apr 26, 2023Novel Immune Checkpoint Inhibitors1
EP3362055Jan 18, 2023Sglt-2 Inhibitor For Use In The Treatment Of A Metabolic Myopathy2
EP2482812Jan 11, 2023Therapeutic Uses Of Pharmaceutical Compositions3
EP2566469Dec 21, 2022Combination Therapy2
EP3517539Dec 14, 2022Substituted Dimeric Quinazoline Derivative, Its Preparation And Its Use In Pharmaceutical Compositions For The Treatment Of Type I And Ii Diabetes3
EP2849754Sep 14, 2022A Xanthine Derivative As Dpp-4 Inhibitor For Use In The Treatment Of Sirs And/Or Sepsis2
EP2981255Sep 14, 2022Therapeutic Uses Of Empagliflozin10